|
| Status |
Public on May 20, 2009 |
| Title |
OG2-MEF, biological replicate 1 |
| Sample type |
RNA |
| |
|
| Source name |
mouse embryonic fibroblast (MEF) haboring the GFP transgene driven by Oct4 promoter.
|
| Organism |
Mus musculus |
| Characteristics |
cell type: OG2-GFP MEFs prepared from E13.5 embryos.
|
| Growth protocol |
OG2-MEFs were cultured on gelatin-coated dishes in normal MEF media: high-glucose D-MEM (Invitrogen) with 10% FBS, 0.1 mM non-essential amino acids, and 2 mM L-glutamine.
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Total RNA was extracted and purified with RNeasy Plus minikit (Qiagen).
|
| Label |
Biotin
|
| Label protocol |
Biotin-16-UTP-labeled cRNA was synthesized from 500 ng total RNA with the Illumina TotalPrep RNA amplification kit (Ambion AMIL1791, Foster City, CA, USA).
|
| |
|
| Hybridization protocol |
The hybridization mix containing 750 ng of labeled amplified cRNA was prepared according to the Illumina BeadStation 500X System Manual (Illumina, San Diego, CA, USA) using the supplied reagents and GE Healthcare Streptavidin-Cy3 staining solution. Hybridization to the Illumina Array MouseRef-8 v2 was for 18 h at 55 °C on a BeadChip Hyb Wheel.
|
| Scan protocol |
The array was scanned using the Illumina BeadArray Reader.
|
| Description |
Oct4-GFP transgenic mice were from the Jackson Laboratory. OG2-GFP MEFs were prepared from E13.5 embryos.
Gene expression data from MEF cells
|
| Data processing |
The data were analyzed using Bead Array suite software. Rank invariant normalization method was chosen to obtain the signal intensity.
|
| |
|
| Submission date |
May 12, 2009 |
| Last update date |
May 19, 2009 |
| Contact name |
Hongyan Zhou |
| Organization name |
the scripps research institute
|
| Street address |
10550 North Torrey Pines Road
|
| City |
La Jolla |
| State/province |
CA |
| ZIP/Postal code |
92037 |
| Country |
USA |
| |
|
| Platform ID |
GPL6885 |
| Series (1) |
| GSE16062 |
Generation of Induced Pluripotent Stem Cells using Recombinant Proteins |
|
